GlaxoSmithKline PLC is a pharmaceutical giant that operates on a global scale. The company has already released research and medications that saved millions of lives. Explore the global leaders of ...

This removed any intermediate doubt that weakening respiratory revenue would cause the company to drastically cut its dividend. Also, considering its 9.3 billion transaction gain, GlaxoSmithKline ...

News about GlaxoSmithKline PLC., including commentary and archival articles published in The New York Times.

LONDON -- Sir Richard Sykes, the mastermind behind the merger that created drug giant GlaxoSmithKline PLC, said he plans ... in day-to-day activities of the company has increasingly dwindled ...

Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against ...

GlaxoSmithKline PLCGSK-0.10%decrease; red down pointing triangle on Monday said it would buy cancer-focused drug company Tesaro Inc. for about $4.16 billion, positioning the health-care giant in a ...

This method should give us information to assess how appropriately the company pays the CEO. At the time of writing, our data says that GlaxoSmithKline plc has a market cap of UK£70b, and ...

Glaxosmithkline Plc has filed a 13D form with the SEC disclosing ownership of 39,660,487 shares of 23andMe Holding Co. Class A (ME). This represents 13.2% of the company. 23andMe Holding Co., a ...

China has granted a green light for Glaxosmithkline plc’s human papillomavirus (HPV ... imported two-dose HPV vaccine for the age group to be approved in China, the company said. A three-dose schedule ...

Arexvy was the first RSV vaccine approved in the European Economic Area for the prevention of lower respiratory tract disease caused by RSV in adults aged 60 and older, and for those aged 50 to 59 ...

GlaxoSmithKline, the pharmaceutical company, said on Wednesday that it had fired Dr. Slaoui from his position as chairman of Galvani Bioelectronics. La revisión positiva probablemente asegure que ...